¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"relative field"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • geometric field distortion artifact
    ±âÇÏÇÐÀûÀÚÀå¿Ö°îÀΰø¹°
  • geometric field separation
    ±âÇÏÇÐÀûÁ¶»ç¿µ¿ªºÐ¸®
  • gradient magnetic field
    ±â¿ï±âÀÚ±âÀå, °æ»çÀÚ±âÀå
  • gravitational field
    Áß·ÂÀå
  • high field magnetic resonance scanner
    °íÀÚÀåÀÚ±â°ø¸í½ºÄ³³Ê
  • horizontal field magnet
    ¼öÆò¸éÀÚ¼®
  • irradiation field
    ¹æ»ç¼±Á¶»ç¿µ¿ª, ¹æ»ç¼±ÂØÀÓ¿µ¿ª
  • incongruous field defect
    ºÒÀÏÄ¡½Ã¾ß°á¼Õ
  • intermediate field magnetic resonance scanner
    ÁßµîÀÚÀåÀÚ±â°ø¸í½ºÄ³³Ê
  • kinetic visual field
    µ¿Àû½Ã¾ß
  • low field magnetic resonance scanner
    ÀúÀÚÀåÀÚ±â°ø¸í½ºÄ³³Ê
  • minimum audible field
    ÃÖ¼Òû°¢¿µ¿ª
  • multiple field irradiation
    ¿©·¯¿µ¿ªÁ¶»ç
  • magnet field homogeneity
    ÀÚÀå±ÕÁú¼º
  • magnetic field
    ÀÚ(±â)Àå
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • field defect
    ½Ã¾ß°á¼Õ
  • incongruous field defect
    ºÒÀÏÄ¡½Ã¾ß°á¼Õ
  • visual field defect
    ½Ã¾ß°á¼Õ
  • electric field
    Àü±âÀå
  • magnetic field effect
    ÀÚ±âÀåÈ¿°ú
  • pulsed-field gel electrophoresis
    °£Ç濵¿ª°ÖÀü±âÀ̵¿
  • visual field examination
    ½Ã¾ß°Ë»ç
  • field
    ºÐ¾ß, ¿µ¿ª, ºÎÀ§, ¹üÀ§, ½Ã¾ß, Àü±âÀå
  • field inhomogeneity
    ÀÚÀåºÒ±ÕÀÏ
  • field strength
    ÀÚÀå¼¼±â
  • field survey
    ÇöÁöÁ¶»ç
  • field test
    ½ÇÁõ°Ë»ç
  • field tourniquet
    ¾ß¿Ü¿ë¾Ð¹Ú¶ì
  • field uniformity
    Á¶»ç¿µ¿ª±ÕÀϼº, Á¶»ç¸é±ÕÀϼº
  • fringe field
    ÁÖº¯¿µ¿ª
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • relative hepatic dullness
    »ó´ë°£Å¹À½°è(ßÓÓßÊÜöúëåÍ£).
  • relative hepatic dullness
    »ó´ë°£Å¹À½°è(ßÓÓßÊÜöúëåÍ£)
  • relative humidity
    »ó´ë½Àµµ
  • relative immunity
    »ó´ë¸é¿ª(¡­Øóæ¹).
  • relative incompetence
    »ó´ë¼º ºÎÀü(¡­àõÝÕîï).
  • relative incompetence
    »ó´ë¼º ºÎÀü(ßÓÓßàõÝÕîï)
  • relative leukocytosis
    ºñ±³¹éÇ÷±¸Áõ°¡Áõ(ÝïÎòÛÜúìϹñòÊ¥ñø).
  • relative leukocytosis
    ºñ±³¹éÇ÷±¸Áõ°¡Áõ(ÝïÎòÛÜúìϹñòÊ¥ñø)
  • relative measurement
    ºñ±³ÃøÁ¤(ËÓË´Ì¬Ëø).
  • relative metabolic rate
    »ó´ëÀû ´ë»çÀ².
  • relative motion
    »ó´ë¿îµ¿(ßÓÓßê¡ÔÑ).
  • relative osteoid volume
    »ó´ëÀû À¯°ñ·®
  • relative polycythemia
    »ó´ëÀû ÀûÇ÷±¸Áõ°¡Áõ(ßÓÓßîÜîåúìϹñòÊ¥ñø).
  • relative polycythemia
    »ó´ëÀû ÀûÇ÷±¸Áõ°¡Áõ(ßÓÓßîÜîåúìϹñòÊ¥ñø)
  • relative refractory period
    »ó´ë(Àû) ºÒÀÀ±â(ßÓÓßîÜÝÕëëÑ¢).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • relative risk estimation
    »ó´ë(-Àû) À§Çèµµ ÃßÁ¤(õÏïÒ)
  • relative scotoma
    »ó´ë¾ÏÁ¡(ßÓÓßäÞïÇ).
  • relative sterility
    »ó´ëÀû »ý½ÄºÒ´É(Áõ)(ßÓÓßîÜßæãÖÝÕÒö(ñø)).
  • relative survival rate
    »ó´ë»ýÁ¸À²
  • relative valvular insufficiency
    »ó´ëÀû ÆÇÆó¼âºÎÀü(Áõ)(ßÓÓßîÜ÷ûøÍáðÝÕîïñø ).
  • relative valvular insufficiency
    »ó´ëÀû ÆÇÆó¼âºÎÀü(Áõ)(ßÓÓßîÜ÷ûøÍáðÝÕîïñø)
  • relative viscosity
    »ó´ëÁ¡µµ(ßÓÓßïÄöô).
  • resource based relative value scale(RBRVS)
    Áö¿ø±âÁØ »ó´ë°¡Ä¡, ÀÇ·á¼ö°¡ Ã¥Á¤ÀÇ Åä´ë·Î Ȱ¿ëµÊ.
  • resource-based relative value system
    ÀÚ¿ø¿¡ ±Ù°ÅÇÑ »ó´ëÀû °¡Ä¡Ã¼°è
  • time dependent relative risk model
    ½Ã°£ÀÇÁ¸¼º »ó´ëÀ§Çè¸ðµ¨
  • abutted field
    ÀÎÁ¢Á¶»ç¸é, -¿µ¿ª, Á¢ÃËÁ¶»ç¸é
  • altitudinal visual field defect
    ¼öÆò½Ã¾ß°á¼Õ
  • auditory field
    û¿ª, û¾ß
  • binocular field
    ¾ç¾È½Ã¾ß
  • blue-field entopic phenomenon
    û»ö½Ã¾ß³»½ÃÇö»ó
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • slice selection gradient field
    ÀýÆí¼±Åðæ»çÀå
  • sound field
    À½¿ª
  • static field
    Á¤ÀÚÀå
  • static field inhomogeneity
    Á¤ÀÚÀåºÒ±ÕÁú
  • static magnetic field
    Á¤ÀÚÀå
  • super high field MR scanner
    ÃʰíÀÚÀåMR½ºÄ³³Ê, ÃʰíÀÚÀåÀÚ±â°ø¸í½ºÄ³³Ê
  • ultra high field MR scanner
    ÃʰíÀÚÀåÀÚ±â°ø¸í½ºÄ³³Ê
  • ultra low field MR scanner
    ÃÊÀúÀÚÀåÀÚ±â°ø¸í½ºÄ³³Ê
  • upper lung field
    »óÆó±¸¿ª, »óÆó¾ß
  • vertical field magnet
    ¼öÁ÷ÀÚÀåÀÚ¼®
  • visual field defect
    ½Ã¾ß°á¼Õ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
QF quality factor; query fever; quick freeze; relative biological effectiveness
RAPD relative afferent pupillary defect
RBA relative binding affinity; rescue breathing apparatus; right basilar artery; right brachial artery; ...
RBD recurrent brief depression; relative biological dose; right border of dullness
RBE relative biological effectiveness
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
RLU Relative Light Units
RO Relative Odds
RP Relative Power
RR Relative Rate
RR Relative Response
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • radio-frequency field
    °íÁÖÆÄ ÀÚÀå
  • receptive field organization
    ¼ö¿ë ¿µ¿ª Á¶Á÷È­
  • resorptive field
    Èí¼ö¾ß
  • sound field
    À½¿ª
  • static field
    Á¤ÀÚÀå
  • static magnetic field
    Á¤ÀÚÀå
  • super high field MR scanner
    ÃʰíÀÚÀå MR ½ºÄ³³Ê, Ãʰí ÀÚÀå Àڱ⠰ø¸í ½ºÄ³³Ê
  • terminal field
    ¸»´ÜºÎ
  • treatment field
    Ä¡·á ¹üÀ§
  • ultra high field MR scanner
    ÃʰíÀÚÀå Àڱ⠰ø¸í ½ºÄ³³Ê
  • visual field defect
    ½Ã¾ß °á¼Õ
    ¸Á¸·¿¡¼­ ´ë³ú ÇÇÁú¿¡ À̸£´Â ½Ã°¢°èÀÇ Àå¾Ö·Î ÀÎÇÑ ½Ã¾ßÀÇ ÀÌ»ó.
  • visual field test
    ½Ã¾ß °Ë»ç
    ÁÖº¯ ½Ã¾ß¿¡ ´ëÇÑ °Ë»ç.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
curvature of field <microscopy> A property of lens that causes the image of a plane to be focused into a curved surface instead of a plane.
The image plane formed by a single lens is naturally curved. While one part of the field will be in good focus, the rest will need refocusing to be sharp. While the eye may partially correct for this, a camera lens will not, and the final image as photographed will not be in perfect focus over the entire image plane.
(05 Aug 1998)
prerubral field See: fields of Forel.
(05 Mar 2000)
pulsed-field gel electrophoresis Gel electrophoresis in which, after electrophoretic migration has begun, the current is briefly stopped and reapplied in a different orientation; allows for the purification of long DNA molecules.
Synonym: pulsed-field gel electrophoresis.
(05 Mar 2000)
pulse field electrophoresis <investigation> A method used for high resolution electrophoretic separation of very large (megabase) fragments of DNA. Electric fields 100
pulse-field gel electrophoresis Gel electrophoresis in which, after electrophoretic migration has begun, the current is briefly stopped and reapplied in a different orientation; allows for the purification of long DNA molecules.
Synonym: pulsed-field gel electrophoresis.
(05 Mar 2000)
nerve field The regional distribution of nerve terminals.
(05 Mar 2000)
dark-field condenser An apparatus for throwing reflected light through the microscope field, so that only the object to be examined is illuminated, the field itself being dark.
(05 Mar 2000)
dark field illumination <microscopy> Any method of illumination which illuminates the specimen but does not admit light directly to the objective. It may be by substage (dark field) condensers, by stagespot lighting, by special condensers fitted around special objectives for reflected illumination or by the slit ultramicroscope.
(05 Aug 1998)
dark field imaging <microscopy> Using a single diffracted beam to form the image in a transmission electron microscope. This causes all regions of the specimen not of the same crystal structure and orientation as the region which produced the diffracted beam to be represented as very dark in the final image, allowing phase differentiation visually in the transmission electron microscope.
(05 Aug 1998)
dark-field microscope <instrument> A microscope that has a special condenser and objective with a diaphragm or stop that scatters light from the object observed, with the result that the object appears bright on a dark background.
(05 Mar 2000)
dark field microscopy <procedure> A system of microscopy in which particles are illuminated at a very low angle from the side so that the background appears dark and the objects are seen by diffracted and reflected patches of light against a dark background.
(18 Nov 1997)
dark field objective <microscopy> Certain objectives for high-power, dark fieldwork equipped with iris diaphragms or funnel stops so that their apertures may be reduced to correspond to the dark field con-denser with which they are used.
(05 Aug 1998)
dark field slides <microscopy> Owing to the exacting demands of dark field illumination, not only must the microscope slide be especially clean, but also the glass of which the slide is composed must be optically clear under dark field conditions. The glass should not fluoresce.
(05 Aug 1998)
dark field stop <microscopy> A central stop for obtaining a dark field effect for low-power objectives. It is customarily used with a high numerical aperture, bright field condenser.
(05 Aug 1998)
depth of field <microscopy> The depth or thickness of the object space that is simultaneously in acceptable focus.
The distance between the closest and farthest objects in focus within a scene as viewed by a lens at a particular focus and with given settings. The depth of field varies with the focal length of the lens and its f-stop setting or numerical aperture, and the wavelength of light. Depth of fields only a small fraction of a micrometre can be achieved at 546 nm with microscope lenses of N.A. Greater than 0.9.
(05 Aug 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • field goal
    Çʵ忡¼­ űÇÏ¿© ¾ò´Â 3Á¡;Çʵå·ÎºÎÅÍÀÇ °ñ
  • field grads
    ¿µ°ü±Þ
  • field gray
    ¾Ïȸ»ö;±ºº¹;µ¶ÀϺ´
  • field gun
    ¾ßÆ÷
  • field hand
    ³óÀå ³ëµ¿ÀÚ
  • field hockey
    À°»ó ÇÏŰ
  • field hospital
    ¾ßÀü º´¿ø
  • field house
    °æ±âÀåÀÇ ºÎ¼Ó °Ç¹°;½Ç³»°æ±âÀå
  • field ice
    ºù¿ø;¾ßºù
  • field intensity
    ÀåÀÇ ¼¼±â;Àü°èÀÇ °­µµ
  • field ion microscope
    À̿ ¹æ»ç Çö¹Ì°æ;Àü°è À̿ Çö¹Ì°æ
  • field jacket
    ¾ßÀü¿ë ÀçŶ
  • field judge
    ÇÊµå ½ÉÆÇ
  • field kitchen
    ¾ß¿Ü(¾ßÀü)Ãë»çÀå
  • field lacrosse
    ¶óÅ©·Î½º
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á